ESR1 and breast cancer: Furthermore, we examined the subtype-specific trends in TCGA breast cancer data and observed that estrogen response and EMT exhibited robust negative correlation primarily in the two ER-positive subtypes (luminal A and luminal B) (51) but not in ER-negative subtypes (HER2+ and basal-like) (Figure 2E).